Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (Weighted Average) (2022 - 2025)

GE HealthCare Technologies' Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $456.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $456.0 million, compared with a TTM value of $456.0 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $456.0 million, changed 0.0% over the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $456.0 million at GE HealthCare Technologies, roughly flat from $457.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $457.0 million in Q1 2025, with the low at $454.0 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $455.4 million, with a median of $455.5 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Weighted Average) changed 0.0% in 2023 and then rose 0.44% in 2024.
  • Tracing GEHC's Shares Outstanding (Weighted Average) over 4 years: stood at $454.0 million in 2022, then grew by 0.22% to $455.0 million in 2023, then rose by 0.22% to $456.0 million in 2024, then changed by 0.0% to $456.0 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Shares Outstanding (Weighted Average) are $456.0 million (Q4 2025), $457.0 million (Q3 2025), and $457.0 million (Q2 2025).